{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:10:29Z","timestamp":1760983829859},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":3371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1093\/annonc\/mdq282","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T03:47:43Z","timestamp":1287460063000},"page":"vii286-vii293","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S7","title":["Multimodality treatment for localized gastro-oesophageal cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"A.F.C.","family":"Okines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq282_bb0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bpg.2006.04.008","article-title":"Gastric cancer: global pattern of the disease and an overview of environmental risk factors","volume":"20","author":"Forman","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1093\/annonc\/mdq282_bb0015","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/1055-9965.EPI-05-0860","article-title":"Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis","volume":"15","author":"Kubo","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdq282_bb0025","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq282_bb0030","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/jnci\/89.17.1277","article-title":"Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia","volume":"89","author":"Gammon","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq282_bb0035","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.1999.17.12.3810","article-title":"Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer","volume":"17","author":"Cirera","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0040","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1054\/bjoc.2000.1472","article-title":"Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up","volume":"84","author":"Neri","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdq282_bb0045","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/annonc\/mdm128","article-title":"Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)","volume":"18","author":"De Vita","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdf040","article-title":"Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group","volume":"13","author":"Bajetta","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0055","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/annonc\/mdi270","article-title":"Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)","volume":"16","author":"Bouche","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0060","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1200\/JCO.1995.13.11.2757","article-title":"Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer","volume":"13","author":"Lise","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0065","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF02307081","article-title":"Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: a Southwest Oncology Group study","volume":"2","author":"Macdonald","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/annonc\/mdj077","article-title":"Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.","volume":"17","author":"Nitti","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0075","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/bjs.5996","article-title":"Randomized controlled trial of adjuvant uracil\u2013tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer","volume":"94","author":"Nakajima","year":"2007","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdq282_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/11024150201680005","article-title":"Chemotherapy in gastric cancer: a review and updated meta-analysis","volume":"168","author":"Janunger","year":"2002","journal-title":"Eur J Surg"},{"key":"10.1093\/annonc\/mdq282_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/bjs.6408","article-title":"Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer","volume":"96","author":"Sun","year":"2009","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdq282_bb0090","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"issue":"15 Suppl","key":"10.1093\/annonc\/mdq282_bb0095","article-title":"Chemoradiation of resected gastric cancer: a 10-year follow-up of the phase III trial INT0116 (SWOG 9008)","volume":"27","author":"Macdonald","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0100","author":"Macdonald","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"18 Suppl","key":"10.1093\/annonc\/mdq282_bb0110","article-title":"Final results of a randomized trial comparing preoperative 5-fluorouracil (F)\/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial","volume":"25","author":"Boige","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"issue":"15 Suppl","key":"10.1093\/annonc\/mdq282_bb0120","article-title":"Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: randomized EORTC phase III trial #40954","volume":"27","author":"Schuhmacher","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdq282_bb0135","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0140","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq282_bb0145","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2006.10.4760","article-title":"Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer","volume":"25","author":"Kelsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq282_bb0155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0160","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","article-title":"Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction","volume":"27","author":"Stahl","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0170","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF02067069","article-title":"Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer","volume":"16","author":"Nygaard","year":"1992","journal-title":"World J Surg"},{"key":"10.1093\/annonc\/mdq282_bb0175","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/1097-0142(19940401)73:7<1779::AID-CNCR2820730702>3.0.CO;2-T","article-title":"A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus","volume":"73","author":"Le Prise","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq282_bb0180","first-page":"391","article-title":"A prospective study of combined therapy in esophageal cancer","volume":"41","author":"Apinop","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"10.1093\/annonc\/mdq282_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq282_bb0190","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdh219","article-title":"A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma","volume":"15","author":"Lee","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0195","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0200","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"issue":"18 Suppl","key":"10.1093\/annonc\/mdq282_bb0205","article-title":"Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)","volume":"27","author":"Van Cutsem","year":"2009","journal-title":"J Clin Oncol"},{"issue":"15 Suppl","key":"10.1093\/annonc\/mdq282_bb0210","article-title":"Assessment of two dosing schedules of GSK1363089 (GSK089), a dual MET\/VEGFR2 inhibitor, in metastatic gastric cancer (GC): interim results of a multicenter phase II study","volume":"27","author":"Jhawer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0215","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","article-title":"Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction","volume":"24","author":"Ott","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq282_bb0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419396899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419396899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/suppl_7\/vii286\/480637\/mdq282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T14:15:11Z","timestamp":1635776111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419396899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":43,"alternative-id":["S0923753419396899"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq282","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}